Cigna Group $CI Shares Bought by CX Institutional

CX Institutional lifted its position in shares of Cigna Group (NYSE:CI) by 10.4% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 21,210 shares of the health services provider’s stock after buying an additional 2,002 shares during the quarter. CX Institutional’s holdings in Cigna Group were worth $6,114,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also modified their holdings of CI. Strategic Blueprint LLC grew its stake in Cigna Group by 9.4% in the 3rd quarter. Strategic Blueprint LLC now owns 1,134 shares of the health services provider’s stock worth $327,000 after acquiring an additional 97 shares during the period. Childress Capital Advisors LLC boosted its holdings in shares of Cigna Group by 5.7% during the third quarter. Childress Capital Advisors LLC now owns 1,329 shares of the health services provider’s stock worth $383,000 after purchasing an additional 72 shares during the last quarter. Park Avenue Securities LLC grew its position in shares of Cigna Group by 5.1% in the third quarter. Park Avenue Securities LLC now owns 18,605 shares of the health services provider’s stock valued at $5,363,000 after purchasing an additional 911 shares during the period. CoreCap Advisors LLC grew its position in shares of Cigna Group by 4.8% in the third quarter. CoreCap Advisors LLC now owns 959 shares of the health services provider’s stock valued at $277,000 after purchasing an additional 44 shares during the period. Finally, Kathmere Capital Management LLC increased its stake in Cigna Group by 7.2% in the third quarter. Kathmere Capital Management LLC now owns 1,459 shares of the health services provider’s stock valued at $421,000 after purchasing an additional 98 shares during the last quarter. Hedge funds and other institutional investors own 86.99% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts have issued reports on CI shares. The Goldman Sachs Group decreased their price target on Cigna Group from $370.00 to $330.00 and set a “buy” rating on the stock in a research note on Tuesday, November 4th. Guggenheim restated a “buy” rating and issued a $318.00 target price on shares of Cigna Group in a report on Tuesday, December 2nd. Cantor Fitzgerald cut their price target on shares of Cigna Group from $365.00 to $325.00 in a research note on Friday, October 31st. Raymond James Financial reiterated a “strong-buy” rating on shares of Cigna Group in a report on Monday, November 3rd. Finally, Jefferies Financial Group restated a “buy” rating and set a $310.00 price objective on shares of Cigna Group in a report on Monday, November 3rd. One research analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and four have assigned a Hold rating to the company. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $333.04.

Cigna Group Price Performance

Cigna Group stock opened at $279.05 on Thursday. The firm has a fifty day moving average of $270.88 and a 200-day moving average of $289.43. Cigna Group has a 52-week low of $239.51 and a 52-week high of $350.00. The company has a quick ratio of 0.76, a current ratio of 0.76 and a debt-to-equity ratio of 0.74. The firm has a market capitalization of $74.54 billion, a P/E ratio of 12.31, a PEG ratio of 1.00 and a beta of 0.26.

Cigna Group (NYSE:CI) last posted its earnings results on Thursday, October 30th. The health services provider reported $7.83 earnings per share for the quarter, beating the consensus estimate of $7.64 by $0.19. Cigna Group had a net margin of 2.29% and a return on equity of 18.80%. The business had revenue of $69.57 billion for the quarter, compared to analyst estimates of $66.40 billion. During the same quarter in the previous year, the business posted $7.51 EPS. The business’s quarterly revenue was up 9.5% on a year-over-year basis. Cigna Group has set its FY 2025 guidance at 29.600- EPS. As a group, analysts predict that Cigna Group will post 29.77 EPS for the current year.

Cigna Group Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Thursday, December 18th. Investors of record on Thursday, December 4th were issued a dividend of $1.51 per share. This represents a $6.04 annualized dividend and a dividend yield of 2.2%. The ex-dividend date was Thursday, December 4th. Cigna Group’s dividend payout ratio (DPR) is presently 26.64%.

Insider Buying and Selling

In related news, CEO David Cordani purchased 4,134 shares of Cigna Group stock in a transaction that occurred on Monday, November 3rd. The shares were purchased at an average cost of $241.88 per share, with a total value of $999,931.92. Following the transaction, the chief executive officer owned 157,935 shares of the company’s stock, valued at approximately $38,201,317.80. The trade was a 2.69% increase in their position. The purchase was disclosed in a filing with the SEC, which can be accessed through this link. Company insiders own 0.70% of the company’s stock.

Cigna Group Company Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.